Another antibody, SIRPαD1-Fc, a novel CD47-targeting fusion protein, increases the autophagy of NSCLC cells by inactivating the Akt/mTOR pathway and increasing ROS levels Table 1. The gene discussed is CD47; the disease is non-small cell lung carcinoma.